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Sleep Disorders in Individuals with Fragile X Syndrome:
A Literature Review
Andrew Alabd, Karim Sedky MD MSc
Cooper Medical School of Rowan University/ Cooper University Hospital, Camden, NJ

BACKGROUND
Fragile X Syndrome (FXS), was first described in
1943 as a form of intellectual disability (ID). A
meta-analysis of fifteen studies that included
7,475 individuals showed that FXS is the second
cause of ID after Down Syndrome (DS). The
disorder is linked to an unstable expansion of
CGG repeat (>200) within the fragile X mental
retardation 1 gene (FMR1) causing a loss of
function in the gene.
The clinical spectrum of FXS is wide including
intellectual disability and other multi-system
symptoms. Therefore, confirmed diagnosis is
made based upon the detection of alterations
to FMR1 gene. While males tend to present with
intellectual disability, females tend to present
with learning disability and less sever intellectual
limitations.
Individuals diagnosed with Fragile X Syndrome
(FXS) are predisposed to sleep disorders including
obstructive sleep apnea (OSA). The aim of this
study is to assess the prevalence of sleep
disorders and comorbid associated sleep
problems in this population along with
appropriate pharmacological and/ or nonpharmacological interventions.
.
METHODS

A literature search was conducted using the
following search engines: google scholar, PubMed,
Ovid, Cochrane library, and PLOS. All English
language published articles were identified by
searching for “Fragile X Syndrome” crossed by
“obstructive sleep apnea” and “sleep problems”.
Literature review was done on selected studies to
assess a possible increased risk of OSA in
individuals with FXS or lack thereof and best
options for management. Crossing OSA, sleep
problems, FXS, and management was used to
identify articles with patient management options
in different populations and their outcomes.

RESULTS
Epidemiology and causes of Sleep Difficulties in FXS

Polysomnography (PSG) has been used as the reference standard for the diagnosis of OSA,
especially in children. Other diagnostic methods were utilized in multiple studies including: pulse
oximetry or parental reports (e.g., studies using OSA-18 questionnaire). However, these later
modalities while cheaper and easier to implement, is not as accurate as the in-laboratory PSG.
Sleep disorders as well as OSA is more common in FXS than in the general population (35-50% in
FXS vs 1-10% in normal children). An analysis of 90 children with FXS using parents reported
CSHQ found that 47% of children with FXS had clinically significant sleep problem. Parents of FXS
patients reported a number of sleep problems including: difficulty falling asleep, frequent
awakening, and restless sleep.
A recent national survey using body mass index (BMI) data from 718 children, found that male
children with FXS had a higher prevalence rate of obesity (31%) when compared to age matched
control children (18%). This higher prevalence of obesity in FXS individuals might be one of the
major contributors to OSA in this population. Other causes includes: narrow oropharynx,
retrognathia, hypotonia and connective tissue disease.

Comorbid Self-Injurious Behavior in FXS Patients with Sleep Difficulties

Self-injurious behavior (SIB) was reported in 58% of the participants, with age of onset around 3
years old. The primary form of frequent (i.e., daily) self-biting or chewing is directed toward the
hand or arm which adds additional challenge and burden to the caregivers of patients with FXS.

Pharmacological and non-pharmacological Interventions

Behavioral strategies including: circadian rhythm management, positive bedtime routines, white
noise, graduated extinction, scheduled awakening and parent training programs showed
significant results in alleviating sleep problems.
Many FXS children might not show adequate response to the above strategies and will benefit
from a pharmacological intervention as melatonin, GABA receptor agonists and alpha-2- agonist.
In a study involving 127 FXS carrier gene compared to 86 controls, RLS symptoms were increased
by 1.9 fold. Since FMRP and FMR1 has been involved in dopamine activity, it is thus expected that
dopaminergic agents might help sleep in this population.
Sample image

CPAP is considered the gold standard treatment for OSA and was shown effective in reducing
symptoms of sleepiness and improving the quality of life measures in patients with moderate and
severe OSA, the compliance to CPAP has long been reported to be poor. Therefore, surgical
interventions can be helpful in alleviating the OSA symptoms in non-compliant and CPAP
refractory patients. Surgical interventions includes: rapid maxillary expansion (RME), mandibular
distraction osteogenesis (MDO), and mini tracheotomies

CONCLUSION
The overall discrepancy in the prevalence of sleep
disorder in children with FXS between the studies
in the literature can probably be attributed to
differences in study design, sample size, and data
collection protocols. However, it appears that
both sleep disorders as well as OSA is more
common in FXS than in the general population.
Patients showed improvement in sleep in
response to behavioral interventions, melatonin,
GABA receptor agonists and alpha-2-agonist.
While CPAP is the gold standard for OSA
treatment, compliance is poor and challenging in
FXS patients. CPAP refractory patients can benefit
from several surgical interventions.
More epidemiological research is needed on
individuals diagnosed with FXS, including a focus
on identifying the possible role that factors such
as gender, age, BMI, and other comorbid medical
problems which may be risk factors for OSA.
.
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